documents: FDA-2019-D-4964-0009
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2019-D-4964-0009 | FDA | FDA-2019-D-4964 | Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Draft Guidance for Industry; Availability; Extension of Comment Period | Notice | Extension of Comment Period | 2020-01-27T05:00:00Z | 2020 | 1 | 2020-01-27T05:00:00Z | 2020-07-28T15:21:43Z | 2020-01322 | 0 | 0 | 09000064842f5943 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref